Get notified when HIMS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Fda Named Company In Statement; Hhs Referred to DOJ (new) — First disclosure of federal enforcement scrutiny targeting compounded GLP-1 marketing and potential drug-law violations.
- Litigation Risk Factor Broadened From 'ordinary Course' to 'legal and Regulatory Proceedings and Inquiries' (worsened) — Reflects non-ordinary regulatory matters including the DOJ referral.
HIMS revenue +38% to $753.2M in Q2 but swings to operating loss on GLP-1 pivot
Filed August 10, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 4, 2025 · ~1 min read
Key Changes
-
high
Operating income swung profit to $97.2M loss YoY while revenue grew 38%, driven by strategic shift to branded GLP-1s with lower margins and higher procurement costs.
MD&A: Operating Results verify on EDGAR → -
high
FDA named the company in Feb 2026 statement targeting compounded GLP-1 marketing; HHS referred HIMS to DOJ for potential violations of drug laws. Outcome unclear but could bring penalties, operational disruptions, or reputational harm.
Risk Factors: FDA/DOJ Investigation verify on EDGAR → -
high
March 2026 strategic shift prioritizes branded GLP-1 medications over compounded alternatives and introduces membership program. Risks include customer unwillingness to pay higher prices, margin compression, and supply-chain dependencies on third-party manufacturers.
Risk Factors: Strategic Shift verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CMTL 10-K) is open in full — no account needed.
Partner
Trade HIMS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 19, 2026 · How we verify